SomaLogic, Inc.
DelistedCIK 1837412fmd_0S4WXW6Q95SFEEY9EN790T4P94Services · Services-Commercial Physical & Biological ResearchTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2023, 15 periods
| Line item | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
| Total revenues | 56 | 82 | 98 |
| Research and development | 31 | 43 | 73 |
| Selling, general and administrative | 37 | 78 | 157 |
| Total operating expenses | 90 | 155 | 273 |
| Operating income | (34) | (73) | (176) |
| Interest expense | 18 | 1 | 0 |
| Interest and investment income | 0 | 0 | 8 |
| Other non-operating income (expense) | (19) | (14) | 66 |
| Income before taxes | – | (88) | (110) |
| Income tax expense | 0 | 0 | (1) |
| Net income from continuing operations | – | (88) | (109) |
| Net income | (53) | (88) | (109) |